These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 19007836)

  • 1. Efficacy of bp26 and bp26/omp31 B. melitensis Rev.1 deletion mutants against Brucella ovis in rams.
    Grilló MJ; Marín CM; Barberán M; de Miguel MJ; Laroucau K; Jacques I; Blasco JM
    Vaccine; 2009 Jan; 27(2):187-91. PubMed ID: 19007836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
    Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM
    Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
    Jacques I; Verger JM; Laroucau K; Grayon M; Vizcaino N; Peix A; Cortade F; Carreras F; Guilloteau LA
    Vaccine; 2007 Jan; 25(5):794-805. PubMed ID: 17070627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual virulence and immunogenicity of CGV26 and CGV2631 B. melitensis Rev. 1 deletion mutant strains in sheep after subcutaneous or conjunctival vaccination.
    Guilloteau LA; Laroucau K; Olivier M; Grillo MJ; Marin CM; Verger JM; Blasco JM
    Vaccine; 2006 Apr; 24(17):3461-8. PubMed ID: 16519974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams.
    Muñoz PM; Estevan M; Marín CM; Jesús De Miguel M; Jesús Grilló M; Barberán M; Irache JM; Blasco JM; Gamazo C
    Vaccine; 2006 Mar; 24(11):1897-905. PubMed ID: 16337315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of recombinant Omp31 from Brucella melitensis in rams and serum bactericidal activity against B. ovis.
    Estein SM; Cheves PC; Fiorentino MA; Cassataro J; Paolicchi FA; Bowden RA
    Vet Microbiol; 2004 Sep; 102(3-4):203-13. PubMed ID: 15327795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Brucella melitensis Rev. 1 vaccine against Brucella ovis infection in rams.
    Fensterbank R; Pardon P; Marly J
    Ann Rech Vet; 1982; 13(2):185-90. PubMed ID: 7168540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minor nucleotide substitutions in the omp31 gene of Brucella ovis result in antigenic differences in the major outer membrane protein that it encodes compared to those of the other Brucella species.
    Vizcaíno N; Kittelberger R; Cloeckaert A; Marín CM; Fernández-Lago L
    Infect Immun; 2001 Nov; 69(11):7020-8. PubMed ID: 11598077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
    Cassataro J; Pasquevich KA; Estein SM; Laplagne DA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH; Goldbaum FA
    Vaccine; 2007 May; 25(22):4437-46. PubMed ID: 17442465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of possible correlates of protective response against Brucella ovis infection in rams immunized with the B. melitensis Rev 1 vaccine.
    Galindo RC; Muñoz PM; de Miguel MJ; Marin CM; Blasco JM; Gortazar C; Kocan KM; de la Fuente J
    Vaccine; 2009 May; 27(23):3039-44. PubMed ID: 19428917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope mapping of the Brucella melitensis BP26 immunogenic protein: usefulness for diagnosis of sheep brucellosis.
    Seco-Mediavilla P; Verger JM; Grayon M; Cloeckaert A; Marín CM; Zygmunt MS; Fernández-Lago L; Vizcaíno N
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):647-51. PubMed ID: 12853399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of humoral and cellular immune responses to BP26 and OMP31 epitopes in the attenuated Brucella melitensis vaccinated sheep.
    Wang W; Wu J; Qiao J; Weng Y; Zhang H; Liao Q; Qiu J; Chen C; Allain JP; Li C
    Vaccine; 2014 Feb; 32(7):825-33. PubMed ID: 24370708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of particulate acellular vaccines against Brucella ovis infection in rams.
    Da Costa Martins R; Irache JM; Blasco JM; Muñoz MP; Marín CM; Jesús Grilló M; Jesús De Miguel M; Barberán M; Gamazo C
    Vaccine; 2010 Apr; 28(17):3038-46. PubMed ID: 19887131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of recombinant BP26 protein in serological diagnosis of Brucella melitensis infection in sheep.
    Cloeckaert A; Baucheron S; Vizcaino N; Zygmunt MS
    Clin Diagn Lab Immunol; 2001 Jul; 8(4):772-5. PubMed ID: 11427425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A DNA vaccine coding for the chimera BLSOmp31 induced a better degree of protection against B. ovis and a similar degree of protection against B. melitensis than Rev.1 vaccination.
    Cassataro J; Pasquevich KA; Estein SM; Laplagne DA; Zwerdling A; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH; Goldbaum FA
    Vaccine; 2007 Aug; 25(32):5958-67. PubMed ID: 17600596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rough mutants defective in core and O-polysaccharide synthesis and export induce antibodies reacting in an indirect ELISA with smooth lipopolysaccharide and are less effective than Rev 1 vaccine against Brucella melitensis infection of sheep.
    Barrio MB; Grilló MJ; Muñoz PM; Jacques I; González D; de Miguel MJ; Marín CM; Barberán M; Letesson JJ; Gorvel JP; Moriyón I; Blasco JM; Zygmunt MS
    Vaccine; 2009 Mar; 27(11):1741-9. PubMed ID: 19186196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice.
    Estein SM; Cassataro J; Vizcaíno N; Zygmunt MS; Cloeckaert A; Bowden RA
    Microbes Infect; 2003 Feb; 5(2):85-93. PubMed ID: 12650766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
    Cassataro J; Estein SM; Pasquevich KA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
    Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
    Adone R; Francia M; Ciuchini F
    Vaccine; 2008 Sep; 26(38):4913-7. PubMed ID: 18675869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
    Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD
    Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.